Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04126070
Title Nivolumab + Docetaxel + ADT in Metastatic Hormone Sensitive Prostate Cancer
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Xiao X. Wei
Indications

prostate adenocarcinoma

Therapies

Docetaxel + Nivolumab

Leuprolide

Goserelin

Degarelix

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.